Skip to content

Dr. Gearóid Tuohy

Eleven Biotherapeutics announces deal with Roche for the licensing of IL-6 antibody technology, including treatments for diabetic macular edema and uveitis.

Eleven Biotherapeutics, Inc. (NASDAQ: EBIO), located in Cambridge Massachusetts, has announced the execution of an exclusive licensing deal with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche… Read More »Eleven Biotherapeutics announces deal with Roche for the licensing of IL-6 antibody technology, including treatments for diabetic macular edema and uveitis.

Natural history study of CNGB3-associated achromatopsia (ACHM) shows that residual cone function in affected patients is highly variable

A natural history study of patients with CNGB3-associated achromatopsia has shown considerable variance in the density of functioning cone cells in patients with the disorder.… Read More »Natural history study of CNGB3-associated achromatopsia (ACHM) shows that residual cone function in affected patients is highly variable